189 related articles for article (PubMed ID: 18585456)
1. Structures of TLR-ligand complexes.
Jin MS; Lee JO
Curr Opin Immunol; 2008 Aug; 20(4):414-9. PubMed ID: 18585456
[TBL] [Abstract][Full Text] [Related]
2. Structures of the toll-like receptor family and its ligand complexes.
Jin MS; Lee JO
Immunity; 2008 Aug; 29(2):182-91. PubMed ID: 18701082
[TBL] [Abstract][Full Text] [Related]
3. Structural biology of the Toll-like receptor family.
Kang JY; Lee JO
Annu Rev Biochem; 2011; 80():917-41. PubMed ID: 21548780
[TBL] [Abstract][Full Text] [Related]
4. Structures and recognition modes of toll-like receptors.
Gao D; Li W
Proteins; 2017 Jan; 85(1):3-9. PubMed ID: 27699870
[TBL] [Abstract][Full Text] [Related]
5. Sensing of microbial molecular patterns by Toll-like receptors.
Song DH; Lee JO
Immunol Rev; 2012 Nov; 250(1):216-29. PubMed ID: 23046132
[TBL] [Abstract][Full Text] [Related]
6. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins.
Carpenter S; O'Neill LA
Biochem J; 2009 Jul; 422(1):1-10. PubMed ID: 19627256
[TBL] [Abstract][Full Text] [Related]
7. Two modes of ligand recognition by TLRs.
Brodsky I; Medzhitov R
Cell; 2007 Sep; 130(6):979-81. PubMed ID: 17889640
[TBL] [Abstract][Full Text] [Related]
8. Roles for accessory molecules in microbial recognition by Toll-like receptors.
Miyake K
J Endotoxin Res; 2006; 12(4):195-204. PubMed ID: 16953972
[TBL] [Abstract][Full Text] [Related]
9. TLR accessory molecules.
Akashi-Takamura S; Miyake K
Curr Opin Immunol; 2008 Aug; 20(4):420-5. PubMed ID: 18625310
[TBL] [Abstract][Full Text] [Related]
10. Structure of toll-like receptors.
Gay NJ; Gangloff M
Handb Exp Pharmacol; 2008; (183):181-200. PubMed ID: 18071660
[TBL] [Abstract][Full Text] [Related]
11. The role of protein-protein interactions in Toll-like receptor function.
Berglund NA; Kargas V; Ortiz-Suarez ML; Bond PJ
Prog Biophys Mol Biol; 2015 Oct; 119(1):72-83. PubMed ID: 26144017
[TBL] [Abstract][Full Text] [Related]
12. Pathogen recognition: TLRs throw us a curve.
Kirk P; Bazan JF
Immunity; 2005 Oct; 23(4):347-50. PubMed ID: 16226500
[TBL] [Abstract][Full Text] [Related]
13. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
14. Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep.
Kramer BW; Kallapur SG; Moss TJ; Nitsos I; Newnham JP; Jobe AH
Innate Immun; 2009 Apr; 15(2):101-7. PubMed ID: 19318420
[TBL] [Abstract][Full Text] [Related]
15. Innate immune sensing and activation of cell surface Toll-like receptors.
Tapping RI
Semin Immunol; 2009 Aug; 21(4):175-84. PubMed ID: 19493685
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors in inflammation, infection and cancer.
Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors, inflammation and cancer.
Tsan MF
Semin Cancer Biol; 2006 Feb; 16(1):32-7. PubMed ID: 16153858
[TBL] [Abstract][Full Text] [Related]
18. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond.
Lahiri A; Das P; Chakravortty D
Vaccine; 2008 Dec; 26(52):6777-83. PubMed ID: 18835576
[TBL] [Abstract][Full Text] [Related]
19. TLR signaling by tumor and immune cells: a double-edged sword.
Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]